Replication in restenotic atherectomy tissue
- PMID: 10996346
- DOI: 10.1016/s0021-9150(99)00457-8
Replication in restenotic atherectomy tissue
Abstract
Previously, we demonstrated that replication in restenotic coronary atherectomy specimens was an infrequent and modest event. In general, this data was interpreted with caution, as immunocytochemistry for the proliferating cell nuclear antigen (PCNA) was used to subjectively assess proliferation and most of the tissue specimens were resected more than 3 months after the initial interventional procedure. The purpose of the present study was to use a more sensitive method of detecting replication, in situ hybridization for histone 3 (H3) mRNA, to determine the replication profile of human directional atherectomy specimens. Restenotic directional coronary atherectomy specimens from lesions that had undergone an interventional procedure within the preceding 3 months were studied. In addition, larger atherectomy specimens from peripheral arterial lesions were assessed to ensure that pockets of replication were not being overlooked in the smaller coronary specimens. We found evidence for replication in tissue resected from 2/17 coronary and 9/12 peripheral artery restenotic lesions. In contrast, 3/11 specimens resected from primary lesions of peripheral arteries also expressed H3 mRNA. We estimated that the maximum percentage of cells that were replicating in restenotic coronary, restenotic peripheral and primary peripheral artery tissue slides to be <0.5, < or =1.2 and <0.01%, respectively. Replication was found in tissue specimens resected both early and late after a previous interventional procedure. For specimens with >15 replicating cells per slide we found high levels of focal replication. Therefore, cell replication, as assessed by the expression of H3 mRNA, was infrequent in restenotic coronary artery specimens, whereas peripheral restenotic lesions had more frequent and higher levels of replication regardless of the interval from the previous interventional procedure. For all specimens the percentage of cells that were replicating was low, however focal areas with relatively high replication indices were presented. Although replication was more abundant in restenotic lesions it does not appear to be a dominant event in the pathophysiology of restenosis.
Similar articles
-
Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy.Circ Res. 1993 Aug;73(2):223-31. doi: 10.1161/01.res.73.2.223. Circ Res. 1993. PMID: 8101140
-
Proliferative activity in coronary atherectomy tissue. Clinical, histopathologic, and immunohistochemical correlates.Chest. 1995 Sep;108(3):815-20. doi: 10.1378/chest.108.3.815. Chest. 1995. PMID: 7656639
-
Beta ig-h3, a transforming growth factor-beta-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions.Arterioscler Thromb Vasc Biol. 1996 Apr;16(4):576-84. doi: 10.1161/01.atv.16.4.576. Arterioscler Thromb Vasc Biol. 1996. PMID: 8624780
-
Pathophysiological insights from studies of retrieved coronary atherectomy tissue.Semin Interv Cardiol. 2000 Dec;5(4):167-73. doi: 10.1053/siic.2000.0136. Semin Interv Cardiol. 2000. PMID: 11176010 Review.
-
Induction of tissue inhibitor of metalloproteinase and its mitogenic response to endothelial cells in human atherosclerotic and restenotic lesions.Can J Cardiol. 1996 Apr;12(4):353-62. Can J Cardiol. 1996. PMID: 8608454 Review.
Cited by
-
Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation.J Vasc Surg. 2009 May;49(5):1289-95. doi: 10.1016/j.jvs.2008.11.096. J Vasc Surg. 2009. PMID: 19394554 Free PMC article.
-
FAM3B mediates high glucose-induced vascular smooth muscle cell proliferation and migration via inhibition of miR-322-5p.Sci Rep. 2017 May 23;7(1):2298. doi: 10.1038/s41598-017-02683-3. Sci Rep. 2017. PMID: 28536423 Free PMC article.
-
The effects of pigment epithelium-derived factor on atherosclerosis: putative mechanisms of the process.Lipids Health Dis. 2018 Oct 17;17(1):240. doi: 10.1186/s12944-018-0889-z. Lipids Health Dis. 2018. PMID: 30326915 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous